Skip to content

Medical-device intelligence

OQO: Herpes Simplex Virus Nucleic Acid Amplification Assay

FDA product code OQO: Herpes Simplex Virus Nucleic Acid Amplification Assay. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OQO
FDA device name
Herpes Simplex Virus Nucleic Acid Amplification Assay
Device class
2
Regulation number
866.3305
Medical specialty
Microbiology
Review panel
MI

FDA definition

A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

12 clearance records and 1 recall records in the covered releases, across 13 source company names and 1 product codes. Dated history runs from May 12, 2010 to May 12, 2020.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OQO · Herpes Simplex Virus Nucleic Acid Amplification Assay121

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
MOL2150 Simplexa HSV 1&2 Direct -CSF -Genital Swab -Cutaneous / Mucocutaneous Swabs Product Usage: is intended for use on the LIAISON MDX instrum…Z-2547-2020 · OQODiaSorin Molecular LLCRecallJul 10, 2020FDA classification date
Sentosa SA201 HSV 1/2 Qualitative PCR TestK172509 · OQOVela Diagnostics USA, Inc.510(k)Feb 1, 2018FDA decision date
Aptima Herpes Simplex Viruses 1 & 2 AssayK162673 · OQOHologic, Inc.510(k)Jun 15, 2017FDA decision date
Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackK150962 · OQOFocus Diagnostics510(k)Aug 28, 2015FDA decision date
cobas HSV 1 and 2 TestK150617 · OQORoche Molecular Systems, Inc.510(k)Jun 1, 2015FDA decision date
SEEGENE ANYPLEX II HSV-1/2 ASSAYK142156 · OQOSeegene510(k)Feb 13, 2015FDA decision date
artus HSV-1/2 QS-RGQ MDx KitK142738 · OQOQiagen510(k)Dec 19, 2014FDA decision date
IMDX HSV-1/2 FOR ABBOTT M2000K140198 · OQOIntelligent Medical Devices, Inc.510(k)May 13, 2014FDA decision date
AMIPLIVUE HSV 1&2 ASSAYK140029 · OQOQuidel Corporation510(k)Mar 26, 2014FDA decision date
ISOAMP HSV ASSAYK111951 · OQOBiohelix Corporation510(k)Sep 27, 2011FDA decision date
MULTICODE-RTX HERPES SIMPLEX VIRUS 1 & 2 KITK111527 · OQOEragen Biosciences, Inc.510(k)Aug 3, 2011FDA decision date
BD PROBETEC HERPES SIMPLEX VIRUSES (HSV 1& 2) Q AMPLIFIED DNA ASSAYSK103798 · OQOBecton, Dickinson & CO510(k)Mar 18, 2011FDA decision date
MULTICODE - RTX HERPES SIMPLEX VIRUS 1 AND 2 KIT, MODEL 3711K100336 · OQOEragen Biosciences510(k)May 12, 2010FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗